Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedJul 11, 2025
DataAggregated Company Financials
Companies7
  • 7D1.9%
  • 3M10.6%
  • 1Y-3.0%
  • YTD2.3%

Over the last 7 days, the Life Sciences industry has risen 1.9%, driven by gains from Lonza Group of 0.7%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 12 Jul 2025CHF 53.1bCHF 10.1bCHF 1.0b33.8x51.1x5.3x
Mon, 09 Jun 2025CHF 53.4bCHF 10.1bCHF 1.0b32.2x51.4x5.3x
Wed, 07 May 2025CHF 54.2bCHF 10.1bCHF 1.0b30.3x52.2x5.4x
Fri, 04 Apr 2025CHF 50.5bCHF 10.1bCHF 1.0b29.9x49.2x5x
Sun, 02 Mar 2025CHF 54.5bCHF 10.1bCHF 1.0b31.2x52.2x5.4x
Tue, 28 Jan 2025CHF 57.2bCHF 10.2bCHF 943.2m36.4x60.6x5.6x
Thu, 26 Dec 2024CHF 52.4bCHF 10.2bCHF 943.5m35.4x55.5x5.1x
Sat, 23 Nov 2024CHF 52.9bCHF 10.2bCHF 943.7m40.8x56.1x5.2x
Mon, 21 Oct 2024CHF 56.1bCHF 10.2bCHF 943.4m42.3x59.5x5.5x
Wed, 18 Sep 2024CHF 56.2bCHF 10.2bCHF 937.0m44.1x60x5.5x
Fri, 16 Aug 2024CHF 56.8bCHF 10.2bCHF 914.5m45.4x62.1x5.6x
Sun, 14 Jul 2024CHF 55.4bCHF 10.3bCHF 1.0b47.5x55.3x5.4x
Tue, 11 Jun 2024CHF 53.1bCHF 10.3bCHF 1.0b43.6x53x5.2x
Thu, 09 May 2024CHF 55.0bCHF 10.3bCHF 1.0b43.6x54.9x5.4x
Sat, 06 Apr 2024CHF 57.1bCHF 10.3bCHF 1.0b45.4x56.9x5.6x
Mon, 04 Mar 2024CHF 50.7bCHF 10.2bCHF 982.2m47x51.7x5x
Wed, 31 Jan 2024CHF 47.0bCHF 10.2bCHF 1.0b41.6x46.1x4.6x
Fri, 29 Dec 2023CHF 41.8bCHF 9.8bCHF 1.5b32.4x28x4.3x
Sun, 26 Nov 2023CHF 41.4bCHF 9.8bCHF 1.5b29.9x27.7x4.2x
Tue, 24 Oct 2023CHF 37.8bCHF 9.8bCHF 1.5b26.5x25.3x3.9x
Thu, 21 Sep 2023CHF 48.2bCHF 9.8bCHF 1.5b33.4x32.3x4.9x
Sat, 19 Aug 2023CHF 51.5bCHF 9.7bCHF 1.5b40.3x33.6x5.3x
Mon, 17 Jul 2023CHF 56.4bCHF 9.7bCHF 1.6b36.1x34.5x5.8x
Wed, 14 Jun 2023CHF 59.0bCHF 9.7bCHF 1.6b37.5x36.1x6.1x
Fri, 12 May 2023CHF 60.7bCHF 9.7bCHF 1.6b40x37.1x6.3x
Sun, 09 Apr 2023CHF 59.4bCHF 9.7bCHF 1.7b41.6x35.6x6.1x
Tue, 07 Mar 2023CHF 59.6bCHF 9.6bCHF 1.7b34.4x35.9x6.2x
Thu, 02 Feb 2023CHF 55.0bCHF 9.6bCHF 1.6b31.8x33.6x5.8x
Sat, 31 Dec 2022CHF 50.7bCHF 9.2bCHF 1.3b37x38.1x5.5x
Mon, 28 Nov 2022CHF 54.9bCHF 9.2bCHF 1.3b41.1x41.3x6x
Wed, 26 Oct 2022CHF 54.0bCHF 9.2bCHF 1.3b42.3x40.6x5.9x
Fri, 23 Sep 2022CHF 47.8bCHF 9.2bCHF 1.3b37.2x37x5.2x
Sun, 21 Aug 2022CHF 56.8bCHF 9.0bCHF 1.3b41.4x44.4x6.3x
Tue, 19 Jul 2022CHF 56.3bCHF 8.5bCHF 1.1b34.1x52.2x6.6x
Price to Earnings Ratio

52.2x


Total Market Cap: CHF 56.3bTotal Earnings: CHF 1.1bTotal Revenue: CHF 8.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 44.8x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 51.1x which is higher than its 3-year average PE of 44.8x.
  • The industry is trading close to its 3-year average PS ratio of 5.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 6.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market1.46%
Healthcare2.52%
Life Sciences1.89%
Clinical Research and Equipment1.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LONN Lonza GroupCHF 564.000.7%
+CHF 268.4m
8.9%PE62.6x
SKAN SKAN GroupCHF 72.502.1%
+CHF 33.7m
-9.5%PE42x